Recce Pharmaceuticals Share Price Up on New Trials (ASX:RCE)

The Sydney-based biotechnology company recently announced a phase 1 trial aimed at new classes of synthetic anti-infectives. At the time of writing the Recce Pharmaceuticals Ltd [ASX:RCE]  share price is up 4.40%, to trade at $1.66, on the back of this positive announcement...
Money Morning Australia